The international personalized antigen oncology immunotherapy market is currently experiencing a dynamic period of advancement, fueled by remarkable progress in personalized medicine and a rising knowledge of the immune system's role in combating tumors. Projections indicate a continued expansion in the next years, driven by clinical trials demonst